Columbia Sportswear Company Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments And Risk Management (Tables)

6 Months Ended

Jun. 30, 2018

The following table presents the gross notional amount of outstanding derivative instruments (in thousands):



	June 30, 2018		December 31, 2017		June 30, 2017
Derivative instruments designated as cash flow hedges:
Currency forward contracts	$	493,828	$	448,448	$	314,000
Derivative instruments not designated as cash flow hedges:
Currency forward contracts	419,707		231,161		166,476

The following table presents the balance sheet classification and fair value of derivative instruments (in thousands):



	Balance Sheet Classification	June 30, 2018		December 31, 2017		June 30, 2017
Derivative instruments designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	$	4,692	$	1,648	$	1,648
Currency forward contracts	Other non-current assets	10,516		335		816
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	1,022		9,336		3,151
Currency forward contracts	Other long-term liabilities	327		3,820		1,665
Derivative instruments not designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	2,471		683		505
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	1,873		1,229		916

The following table presents the statement of operations effect and classification of derivative instruments (in thousands):



	Statement of Operations Classification	Three Months Ended June 30,						Six Months Ended June 30,
	Statement of Operations Classification	2018			2017			2018			2017
Currency Forward and Option Contracts:
Derivative instruments designated as cash flow hedges:
Gain (loss) recognized in other comprehensive income or loss, net of tax	—	$	20,859		$	(5,537	)	$	15,627		$	(6,975	)
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion	Net sales	19			—			24			144
Gain (loss) reclassified from accumulated other comprehensive income or loss to income for the effective portion	Cost of sales	(1,398		)	897			(3,604		)	951
Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Net sales	6			2			12			5
Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Cost of sales	1,896			492			3,821			1,286
Derivative instruments not designated as cash flow hedges:
Gain (loss) recognized in income	Other non-operating expense	2,836			(1,723		)	2,234			(3,411		)